Challenges in COVID-19 in Patients with Haematological Malignancies: Case Report of a Patient with Mantle Cell Lymphoma

Authors

  • Sebastian Knorz
  • Susanne Wiebecke
  • Petra Schulze
  • Sven Schimanski
  • Susanne Strifler
  • Tobias Gassenmaier
  • Erdwine Klinker
  • Benedikt Weissbrich
  • Hartwig Klinker

Abstract

Introduction: Patients with haematological malignancies after chemotherapy are immunocompromised and therefore highly susceptible to Covid-19 disease. Case presentation: The case report presents a patient with mantel cell lymphoma who experienced a severe Covid-19 disease. Simultaneously, a pulmonary thromboembolism and a cerebral bleeding were detected, thereafter a cytomegalovirus reactivation. A therapy with convalescent plasma showed just an intermediate effect on the patient´s prolonged positivity for SARS-CoV-2. Conclusion: The management of COVID-19 disease in patients with haematological malignancies is a complex challenge due to the diverse impairment of the immune system. In addition to the underlying disease, opportunistic infections are of great relevance.

Downloads

Published

2021-08-31

How to Cite

Knorz, S., Wiebecke, S., Schulze, P., Schimanski, S., Strifler, S., Gassenmaier, T., … Klinker, H. (2021). Challenges in COVID-19 in Patients with Haematological Malignancies: Case Report of a Patient with Mantle Cell Lymphoma. Archives of Clinical and Medical Case Reports, 5(4), 599–609. Retrieved from https://fortunejournals.org/ojs/index.php/acmcr/article/view/22525